Clinical Trial Update: Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS [Phase 4]

View source ↗

Summary

Phase 4 trial investigating ACTH effects on myelination in subjects with multiple sclerosis; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• ACTH (adrenocorticotropic hormone)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Multiple Sclerosis | Phase 4 | Status: TERMINATED | Results posted: 2021-01-22